Acetic acid 2% + boric acid 2% with surfactants
Product Description
Cipla Ltd
-
IN -
2015On CPHI since
Company types
Categories
Specifications
Cipla Ltd
-
IN
-
2015On CPHI since
Company types
More Products from Cipla Ltd (99)
-
Product Acarbose 25 mg
Cipla Ltd offers wide range of formulation products which includes acarbose 25 mg. Dosage form: tablets. Therapeutic area: diabetology. Packaging type: blister. Contact us for more information. -
Product Acarbose 50 mg
Cipla Ltd offers wide range of formulation products which includes acarbose 50 mg. Dosage form: tablets. Therapeutic area: diabetology. Packaging type: blister. Contact us for more information. -
Product Aceclofenac 100 mg
Cipla Ltd offers wide range of formulation products which includes aceclofenac 100 mg. Dosage form: tablets. Therapeutic area: analgesic / anti-inflammatory / antipyretic. Packaging type: strip. Contact us for more information. -
Product Aceclofenac 100 mg + paracetamol 500 mg
Cipla Ltd offers wide range of formulation products which includes aceclofenac 100 mg + paracetamol 500 mg. Dosage form: tablets. Therapeutic area: analgesic / anti-inflammatory / antipyretic. Packaging type: strip. Contact us for more information. -
Product Aceclofenac 100 mg + serratiopeptidase 15 mg
Cipla Ltd offers wide range of formulation products which includes aceclofenac 100 mg + serratiopeptidase 15 mg. Dosage form: tablets. Therapeutic area: analgesic / anti-inflammatory / antipyretic. Packaging type: strip. Contact us for more information. -
Product Acetazolamide 250 mg
Cipla Ltd offers wide range of formulation products which includes acetazolamide 250 mg. Dosage form: tablets. Therapeutic area: cardiology. Packaging type: container. Contact us for more information. -
Product Acetylcysteine 100 mg/ml
Cipla Ltd offers wide range of formulation products which includes acetylcysteine 100 mg/ml. Dosage form: injection. Therapeutic area: respiratory. Packaging type: ampoule. Contact us for more information. -
Product Acetylcysteine 20% w/v
Cipla Ltd offers wide range of formulation products which includes acetylcysteine 20% w/v. Dosage form: injection. Therapeutic area: respiratory. Packaging type: ampoule. Contact us for more information. -
Product Acetylcysteine 600 mg
Cipla Ltd offers wide range of formulation products which includes acetylcysteine 600 mg. Dosage form: tablets. Therapeutic area: respiratory. Packaging type: strip. Contact us for more information. -
Product Acyclovir 200 mg
Cipla Ltd offers wide range of formulation products which includes acyclovir 200 mg. Dosage form: dispersible tablet. Therapeutic area: antiinfectives. Packaging type: blister. Contact us for more information. -
Product Acyclovir 25 mg
Cipla Ltd offers wide range of formulation products which includes acyclovir 25 mg. Dosage form: infusion. Therapeutic area: antiinfectives. Packaging type: bottle. Contact us for more information. -
Product Acyclovir 250 mg
Cipla Ltd offers wide range of formulation products which includes acyclovir 250 mg. Dosage form: lyophilised injection. Therapeutic area: antiinfectives. Packaging type: vial. Contact us for more information.
Cipla Ltd resources (1)
-
News Cipla and Kemwell to form joint venture targeting respiratory biosimilars market
The agreement is expected to accelerate Cipla’s global lung leadership agenda
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance